Skip to contentSkip to Braille Studio

Library / Laws / 114th Congress / House Bills / H.R. 2841

H.R. 2841

To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.

Print stageDateSize⠃
Introduced in House2015-06-1814.6K⠃⠗⠋